An increasingly common financing strategy for companies expecting to conduct an initial public offering (IPO), particularly in the life sciences space, is to conduct a ‘‘crossover’’ financing shortly prior to the IPO....more
11/21/2017
/ Capital Raising ,
Corporate Financing ,
Disclosure Requirements ,
Due Diligence ,
General Solicitation ,
Initial Public Offering (IPO) ,
Investment Funds ,
Investors ,
Section 5 ,
Securities Act of 1933 ,
Shareholders